secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTEGRATED BIOPHARMA INC (INBP)
CIK:        0001016504
Form:       8-K
Filed at:   2025-04-24T23:59:59+00:00
Accession:  0001437749-25-012917
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Integrated BioPharma replaces auditor Marcum with CBIZ CPAs after Marcum's attest business acquisition
--------------------------------------------------------------------------------

- Marcum LLP resigned as auditor effective April 24, 2025; CBIZ CPAs P.C. engaged for fiscal year ending June 30, 2025.
- Marcum's reports for FY 2024 and 2023 were unqualified, with no adverse opinions or modifications.
- No disagreements or reportable events between the Company and Marcum during the past two fiscal years and interim period.
- No prior consultations with CBIZ CPAs regarding accounting principles, audit opinions, or reportable events.
- Change approved by Audit Committee; Marcum provided a letter to the SEC agreeing with the disclosures.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1016504/000143774925012917/0001437749-25-012917-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1016504/000143774925012917/inbp20250422_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-012917

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer